rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy model

Journal of Orthopaedic Research - Tập 21 - Trang 997-1004 - 2003
R.H Li1, M.L Bouxsein1, C.A Blake1, D D’Augusta1, H Kim1, X.J Li1, J.M Wozney1, H.J Seeherman1
1Wyeth Research, 200 Cambridge Park Drive, Cambridge, MA 02140, USA

Tóm tắt

AbstractThis study evaluated the ability of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) delivered in an injectable calcium phosphate carrier (α‐BSM) to accelerate healing in a rabbit ulna osteotomy model compared to untreated surgical controls. Healing was assessed by radiography, histology and biomechanics. Bilateral mid‐ulnar osteotomies were created in 16 skeletally mature rabbits. One limb in each animal was injected with either 0.1 mg rhBMP‐2/α‐BSM (BMP) (N = 8) or buffer/α‐BSM (BSM) (N = 8). Contralateral osteotomies served as untreated surgical controls (SXCT). Gamma scintigraphy showed 75%, 45% and 5% of the initial 125I‐rhBMP‐2 dose was retained at the osteotomy site at 3 h, 1 week and 3 weeks. The biological activity of rhBMP‐2 (alkaline phosphatase activity from bioassay) extracted from α‐BSM incubated in vitro up to 30 days at 37°C was unchanged. Radiographs demonstrated complete bridging of the BMP limbs at 4 weeks whereas none of the BSM or SXCT limbs were bridged. Post‐mortem peripheral quantitative computed tomography determined mineralized callus area was 62% greater in BMP limbs compared to SXCT limbs. Torsional stiffness and strength were 63% and 103% greater in BMP limbs compared to SXCT limbs. There was no difference in torsional properties between BSM and SXCT limbs. Failure occurred outside the osteotomy in four out of seven of the BMP limbs. All BSM and SXCT limbs failed through the osteotomy. Histology showed bony bridging of the osteotomy and no residual carrier in the BMP limbs. BSM and SXCT groups showed less mature calluses composed of primarily fibrocartilaginous tissue and immature bone in the osteotomy gap. These data indicate rhBMP‐2 delivered in α‐BSM accelerated healing in a rabbit ulna osteotomy model compared to BSM and SXCT groups. © 2003 Orthopaedic Research Society. Published by Elsevier Science Ltd. All rights reserved.

Tài liệu tham khảo

2000, RP‐651147—Orthopedic and Musculoskeletal Markets: Biotechnology and Tissue Engineering, 29 10.1007/s002239900662 BESTT(The BMP‐2 Evaluation in Surgery for Tibial Trauma Study Group), 2002, Recombinant human bone morphogenetic protein‐2 for open tibial fractures: a prospective, controlled, randomized study in 450 patients, J Bone Joint Surg, 84, 2123, 10.2106/00004623-200212000-00001 10.1097/00007632-200002010-00020 10.2106/00004623-200108000-00012 10.1016/j.joms.2005.08.018 EdwardsIR ZabkaA HayashiK et al. Accelerated fracture healing by percutaneous injection of rhBMP‐2 and alpha‐BSM. In: Transactions of the Annual Meeting of the Orthopaedic Research Society Orlando FL 2000. p.850. 10.2106/00004623-199506000-00016 EinhornTA MajeskaRJ MohaideenA et al. A single percutaneous injection of recombinant human bone morphogenetic protein‐2 accelerates fracture repair.J Bone Joint Surg in press. Gerhart TN, 1993, Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein‐2, Clin Orthop, 293, 317 Hanisch O, 1997, Bone formation and osseointegration stimulated by rhBMP‐2 following subantral augmentation procedures in nonhuman primates, Int J Oral Maxillofac Implants, 12, 785 HollingerJ BuckD SchmittJ et al. An injectable endothermically‐setting calcium phosphate material bridges critical‐sized defects in rabbits in combination with rhBMP‐2. Trans ORS1999:509. 10.1902/jop.1997.68.12.1186 10.1002/jbmr.5650101110 10.1016/S8756-3282(00)00358-6 Karladani AH, 2000, Displaced tibial shaft fractures: a prospective randomized study of closed intermedullary nailing versus cast treatment in 53 patients, Acta Orthop Scand, 71, 160, 10.1080/000164700317413139 KimHD LiR D'AugustaDA et al. Injectable hyaluronic acid/tricalcium phosphate composites for the delivery of rhBMP‐2. In: Controlled Release of Bioactive Materials 27th International Symposium Paris France 2000. p.8009. Knaack D, 1997, Novel fully resorbable calcium phosphate bone substitute, J Bone Miner Res, 12, s202 10.1097/00003086-199910001-00038 LiRH SeehermanH BouxseinM et al. Acceleration of fracture healing with rhBMP‐2 delivered in an injectable gelfoam delivery system. In: Sixth World Biomaterials Congress Transactions Society for Biomaterials 2000. p.560. 10.1016/S0167-7799(01)01665-1 Muschler GF, 1994, Evaluation of human bone morphogenetic protein‐2 in a canine fusion model, Clin Orthop, 308, 229, 10.1097/00003086-199411000-00033 10.1097/00003086-199810001-00008 Riedel GE, 1999, Clinical evaluation of rhBMP‐2/ACS in orthopedic trauma: a progress report, Orthopedics, 22, 663 Schenk RK, 1984, Methods of calcified tissue preparation, 1 10.1016/S0278-2391(99)90338-5 SeehermanH AiolovaM BouxseinM WozneyJ. A single injection of rhBMP‐2/calcium phosphate paste accelerates healing in a nonhuman primate osteotomy model. In: Transactions of the Annual Meeting of the Orthopaedic Research Society San Francisco CA 2001. p.251. SeehermanH LiR BlakeC et al. A single injection of rhBMP‐2/calcium phosphate paste given one week after surgery accelerates osteotomy healing by 50% in a non‐human primate fibula osteotomy model. In: Transactions of the 48th Annual Meeting of the Orthopaedic Research Society Dallas TX 2002. p.237. 10.1902/jop.1995.66.2.131 10.1210/en.130.3.1318 Tyllianakis M, 2002, Use of injectable calcium phosphate in the treatment of intra‐articular distal radius fractures, Orthopedics, 25, 311, 10.3928/0147-7447-20020301-14 10.1073/pnas.87.6.2220 10.1359/jbmr.1998.13.9.1483 10.2106/00004623-197759020-00009 10.1016/S0169-409X(97)00126-9 10.1002/mrd.1080320212 10.1126/science.3201241 10.2106/00004623-199712000-00003